Clearstead Advisors’s Cidara Therapeutics CDTX Stock Holding History

Clearstead Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3	Closed	-$663	–	2350
2025 Q4	$663	Buy	+3	New	+$485	﹤0.01%	2279

Clearstead Advisors's CDTX Position: Q1 2026 in Review

Clearstead Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3 shares — an estimated $663 sold.

Clearstead Advisors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $663 in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Clearstead Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Clearstead Advisors sold 3 Cidara Therapeutics shares in Q1 2026, an estimated $663.
Clearstead Advisors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Clearstead Advisors's Cidara Therapeutics position peaked at $663 in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.